Potential strategies for the management of adenocarcinoma: a perspective.

Future Medicinal ChemistryVol. 15, No. 2 CommentaryPotential strategies for the management of adenocarcinoma: a perspectiveParteek Prasher & Mousmee SharmaParteek Prasher *Author for correspondence: E-mail Address: parteekchemistry@gmail.comhttps://orcid.org/0000-0002-9412-9424Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun, 248007, IndiaSearch for more papers by this author & Mousmee Sharma https://orcid.org/0000-0002-7728-5054Department of Chemistry, Uttaranchal University, Dehradun, 248007, IndiaSearch for more papers by this authorPublished Online:20 Feb 2023https://doi.org/10.4155/fmc-2023-0006AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: adenocarcinomaaspartate transaminasepancreatic ductaladenocarcinomahistone methyltransferasesprotein arginine methyltransferase 5polypeptide n-acetylgalactosaminyl transferaseReferences1. Shiratori R, Furuichi K, Yamaguchi M et al. Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci. Rep. 9(1), 18699 (2019).Crossref, Medline, CAS, Google Scholar2. Chen W, Wang W, Zhou L et al. Elevated AST/ALT ratio is associated with all-cause mortality and cancer incident. J. Clin. Lab. Anal. 36(5), e24356 (2022).Crossref, Medline, CAS, Google Scholar3. Chen S-L, Li J-P, Li L-F, Zeng T, He X. Elevated preoperative serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio is associated with better prognosis in patients undergoing curative treatment for gastric adenocarcinoma. Int. J. Mol. Sci. 17(6), 911 (2016).Crossref, Medline, Google Scholar4. Thornburg JM, Nelson KK, Clem BF et al. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res. 10(5), R84 (2008).Crossref, Medline, Google Scholar5. Sun W, Luan S, Qi C et al. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism. Cell Commun. Signal. 17(1), 111 (2019).Crossref, Medline, Google Scholar6. Anglin J, Zavareh RB, Sander PN et al. Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorg. Med. Chem. Lett. 28(16), 2675–2678 (2018).Crossref, Medline, CAS, Google Scholar7. Holt MC, Assar Z, Zavareh RB et al. Biochemical characterization and structure-based mutational analysis provide insight into the binding and mechanism of action of novel aspartate aminotransferase inhibitors. Biochemistry 57(47), 6604–6614 (2018).Crossref, Medline, CAS, Google Scholar8. Ho Y-J, Lin Y-M, Huang Y-C et al. Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma. APMIS 125(11), 985–995 (2017).Crossref, Medline, CAS, Google Scholar9. Yuan G, Hu B, Ma J et al. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma. Cancer Med. doi: 10.1002/cam4.5451 (2022) (Epub ahead of print).Crossref, Google Scholar10. Ibrahim R, Matsubara D, Osman W et al. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial–mesenchymal transition. Hum. Pathol. 45(7), 1397–1405 (2014).Crossref, Medline, CAS, Google Scholar11. Baumert HM, Metzger E, Fahrner M et al. Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death. Cancer Cell Int. 20, 52 (2020).Crossref, Medline, CAS, Google Scholar12. Li Z, Yamada S, Wu Y et al. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection. Oncotarget 7(34), 54463–54473 (2016).Crossref, Medline, Google Scholar13. Lavrsen K, Dabelsteen S, Vakhrushev SY et al. De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium. J. Biol. Chem. 293(4), 1298–1314 (2018).Crossref, Medline, CAS, Google Scholar14. Liu S, Shun C, Hung K et al. Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation. Oncotarget 7, 11251–11262 (2016).Crossref, Medline, Google Scholar15. Kwon O, Oh E, Park J et al. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma. Oncotarget 6, 41916–41928 (2015).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetails Vol. 15, No. 2 STAY CONNECTED Metrics Downloaded 23 times History Received 11 January 2023 Accepted 20 January 2023 Published online 20 February 2023 Published in print January 2023 Information© 2023 Newlands PressKeywordsadenocarcinomaaspartate transaminasepancreatic ductaladenocarcinomahistone methyltransferasesprotein arginine methyltransferase 5polypeptide n-acetylgalactosaminyl transferaseFinancial & competing interests disclosureThis study was supported by a research grant from the Department of Science and Technology–Science and Engineering Research Board, India. P Prasher received a Teachers Associateship For Research Excellence fellowship from the Department of Science and Technology–Science and Engineering Research Board (TAR/2021/000129). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download